Evidence map›Paper›PMID 37138445›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.

Vance G Fowler, David T Durack, Christine Selton-Suty, Eugene Athan, Arnold S Bayer, Anna Lisa Chamis, Anders Dahl, Louis DiBernardo, Emanuele Durante-Mangoni, Xavier Duval and 15 more

Erratum issued Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03272724 (French National Observatory on Infective Endocarditis), which is not on this map. Cited by 461 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
461citing papers in PubMed, 2 pooled it
141.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03272724 recruitingnot on this map

French National Observatory on Infective Endocarditis

TypeobservationalSponsorCentral Hospital, Nancy, FranceRan1991 to 2027Enrolled5,000ConditionsInfective Endocarditis
3 · Its place in the literature

Who cites it

461 citing papers in PubMed, 2 syntheses or guidelines pooled it, 654 citations in OpenAlex.

  1. Dalbavancin for infective endocarditis: A systematic review of effectiveness, safety, and dosing.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Pooled it
  2. Infective Endocarditis byPathogens (Basel, Switzerland) · 2025
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. The Clinical Significance ofOpen forum infectious diseases · 2026
    Article
  7. Clinical and Molecular Characteristics ofOpen forum infectious diseases · 2026
    Article
  8. Article
  9. Article
  10. Diagnosis of atypical coagulase-negative staphylococci in native valve endocarditis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Newly recognized typical microorganisms in intracardiac prosthetic material-related infective endocarditis: evidence behind their inclusion in the 2023 Duke-ISCVID criteria.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

401 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 19 institutions in 12 countries.

Vance G FowlerDivision of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0002-8048-0897
David T DurackDivision of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
Christine Selton-SutyCHU of Nancy, Cardiology Department, CIC-EC, Nancy, France.
Eugene AthanDepartment of Infectious Disease, Barwon Health and School of Medicine, Deakin University, Geelong, Australia.
Arnold S BayerDivision of Infectious Diseases, The Lundquist Institute at Harbor-UCLA, Torrance, California, USA.
Anna Lisa ChamisDivision of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
Anders DahlDepartment of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark.
Louis DiBernardoDivision of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
Emanuele Durante-MangoniDepartment of Precision Medicine, University of Campania 'L. Vanvitelli', Monaldi Hospital, Naples, Italy.
Xavier DuvalAP-HP, Hôpital Bichat, Centre d'Investigation Clinique, INSERM CIC 1425, Université Paris Cité, IAME, INSERM, Paris, France.
Claudio Querido FortesInfectious Diseases Department, Hospital Universitário Clementino Fraga Filho-Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.
Emil FosbølThe Heart Centre, University Hospital of Copenhagen, Rigshospitalet, Denmark.
Margaret M HannanClinical Microbiology Department, Mater Misericordiae University Hospital, University College Dublin, Dublin, Ireland.
Barbara HasseDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital, University of Zurich, Zurich, Switzerland.
Bruno HoenDepartment of Infectious Diseases and Tropical Medicine and Inserm CIC-1424, Université de Lorraine, APEMAC, Nancy, France.
Adolf W KarchmerDivision of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Carlos A MestresDepartment of Cardiothoracic Surgery and the Robert WM Frater Cardiovascular Research Centre, The University of the Free State, Bloemfontein, South Africa.
Cathy A PettiDivision of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
María Nazarena PizziDepartment of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Stephen D PrestonHistopathology, Royal Papworth Hospital, Cambridge, United Kingdom.
Albert RoqueDepartment of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Francois VandeneschCIRI, Centre International de Recherche en Infectiologie, Univ Lyon, INSERM, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.
Jan T M van der MeerDivision of Infectious Diseases, Amsterdam UMC, Amsterdam, The Netherlands.
Thomas W van der VaartDivision of Infectious Diseases, Amsterdam UMC, Amsterdam, The Netherlands.
Jose M MiroInfectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
Duke Medical Center · USAmsterdam University Medical Centers · NLInserm · FRVall d'Hebron Hospital Universitari · ESBarwon Health · AUBeth Israel Deaconess Medical Center · USCentre d’Investigation Clinique Innovation Technologique de Nancy · FRDuke University · USGentofte Hospital · DKInstituto de Salud Carlos III · ESRigshospitalet · DKUniversidade Federal do Rio de Janeiro · BRUniversité Claude Bernard Lyon 1 · FRUniversity College Dublin · IEUniversity of California, Los Angeles · USUniversity of Campania "Luigi Vanvitelli" · ITUniversity of the Free State · ZAUniversity of Ulster · GBUniversity of Zurich · CH

Funding

HLA Fine Mapping to Elucidate S. aureus SusceptibilityR01AI165671 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G., SCOTT, WILLIAM K · 2021 to 2025
$3.8M
NIAID NIH HHS R01 AI165671
6 · The paper itself

Abstract

The microbiology, epidemiology, diagnostics, and treatment of infective endocarditis (IE) have changed significantly since the Duke Criteria were published in 1994 and modified in 2000. The International Society for Cardiovascular Infectious Diseases (ISCVID) convened a multidisciplinary Working Group to update the diagnostic criteria for IE. The resulting 2023 Duke-ISCVID IE Criteria propose significant changes, including new microbiology diagnostics (enzyme immunoassay for Bartonella species, polymerase chain reaction, amplicon/metagenomic sequencing, in situ hybridization), imaging (positron emission computed tomography with 18F-fluorodeoxyglucose, cardiac computed tomography), and inclusion of intraoperative inspection as a new Major Clinical Criterion. The list of "typical" microorganisms causing IE was expanded and includes pathogens to be considered as typical only in the presence of intracardiac prostheses. The requirements for timing and separate venipunctures for blood cultures were removed. Last, additional predisposing conditions (transcatheter valve implants, endovascular cardiac implantable electronic devices, prior IE) were clarified. These diagnostic criteria should be updated periodically by making the Duke-ISCVID Criteria available online as a "Living Document."

Indexed as

Communicable DiseasesEndocarditisEndocarditis, BacterialHeart Valve ProsthesisFluorodeoxyglucose F18HumansPositron-Emission TomographyFluorodeoxyglucose F18Duke CriteriaechocardiographyendocarditisISCVIDPET/CT

Identifiers

PMID37138445
PMCPMC10681650
OpenAlexW4368359961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.